Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Stock Information | RedChip

Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Listen to this Section


$13.43
-0.5300 ( -3.80% ) 746.8K

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Market Data


Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 13 Nov 17, 2023
8-k 8K-related 15 Nov 14, 2023
10-q Quarterly Reports 83 Nov 14, 2023
8-k 8K-related 14 Oct 12, 2023
8-k 8K-related 59 Sep 05, 2023
def Proxies and info statements 7 Aug 22, 2023
10-q Quarterly Reports 84 Aug 11, 2023
8-k 8K-related 15 Aug 11, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.